60 Minutes examines PEPFAR in Uganda

NewsGuard 100/100 Score

CBS News' 60 Minutes reports from Uganda about how PEPFAR has helped people living with HIV/AIDS throughout the country and the challenges Uganda still faces in fighting the spread of the virus. The show includes interviews with Peter Mugyenyi of the Joint Clinical Research Center in Kampala, Uganda, and other doctors on the ground, who discuss how HIV-positive children and adults are alive today as a result of PEPFAR and how the program has helped to improve the way Africans view the United States.

According to the show, "today generic drugs have made AIDS pills much cheaper: treating one patient for a year used to cost more than $7,000; now, it's less than $300."

"But even with American aid, the battle is far from over," 60 Minutes reports, noting how "several sexual customs in Uganda make AIDS hard to contain," such as polygamy and cross-generational sex. The show examines Uganda's abstinence, be faithful and use condoms approach to preventing infection, and the U.S. support of such efforts. In addition, 60 Minutes looks at Uganda's efforts to boost the number of people getting tested for HIV, which the U.S. is helping fund. 

The show also examines concerns among Ugandans that the U.S. will be forced to scale back its support of HIV/AIDS programs on the ground. A full video from the program is available here.

CBSNews.com features several video segments from the program, including an interview with Cissy Ssuuna, a nurse and counselor at the Pediatric Infectious Disease Clinic at Mulago Hospital in Kampala, Uganda, who discusses how the treatment of children living with HIV in Uganda has changed over the past five years. Links to the video segments appear here and here (4/4).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Measles and rubella vaccine delivered via microarray patch shows promising results